Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Daiichi Sankyo 2
Trials & R&D · first seen 14h ago, updated 14h ago

Kyverna builds case for CAR-T in stiff person syndrome

1 outlet CAR-T & cell therapy

Kyverna builds case for CAR-T in stiff person syndrome Phil.Taylor Thu, 24/09/2026 - 11:58

Summary from pharmaphorum.

Coverage 1 article · 1 outlet

  1. pharmaphorum
    Kyverna builds case for CAR-T in stiff person syndrome